Fixed drug eruption caused by mefenamic acid: A case series and diagnostic algorithms;Fixes arzneimittelexanthem auf mefenaminsäure: Eine fallserie und diagnostische algorithmen

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue 5, 2011, Pages 374-378

  Handisurya, Alessandra ^a   Moritz, Katharina Barbara ^a   Riedl, Elisabeth ^a   Reinisch, Christina ^a   Stingl, Georg ^a   Wöhrl, Stefan ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

adverse drug reaction; fixed drug eruption; mefenamic acid; non steroidal anti inflammatory drugs; patch test in loco; provocation tests

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CAFFEINE; CELLULOSE; DODECYL SULFATE SODIUM; FLUFENAMIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; IRON OXIDE; MACROGOL; MAGNESIUM STEARATE; MEFENAMIC ACID; METHYLCELLULOSE; MOBILISIN; PARACETAMOL; SILICON DIOXIDE; TALC; TITANIUM; UNCLASSIFIED DRUG; VANILLIN;

ADULT; ARTICLE; CASE REPORT; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA MULTIFORME; FIXED DRUG ERUPTION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; LEUKOCYTOSIS; MALE; NEUTROPHILIA; PENIS GLANS; PROVOCATION TEST;

ADULT; ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ERUPTIONS; HUMANS; MALE; MEFENAMIC ACID; MIDDLE AGED;

EID: 79955066938     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07621.x     Document Type: Article

References (29)

1. Bourns DCG,. Unusual effects of antipyrine. Br Med J 1889; 2: 218-20.
2. Brocq L,. Eruption érythémato-pigmentée fixe due a l'antipyrine. Ann Dermatol Vénéréol 1894; 5: 308-13.
3. Posadas SJ, Pichler WJ,. Delayed drug hypersensitivity reactions-new concepts. Clin Exp Allergy 2007; 37 (7): 989-99. (Pubitemid 46955519)
4. Mizukawa Y, Shiohara T,. Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Curr Allergy Asthma Rep 2009; 9 (1): 71-7.
5. Shiohara T, Mizukawa Y,. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells. Eur J Dermatol 2007; 17 (3): 201-8. (Pubitemid 46847781)
6. Mizukawa Y, Yamazaki Y, Shiohara T,. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption. Br J Dermatol 2008 Jun; 158 (6): 1230-8. (Pubitemid 351692861)
7. Mizukawa Y, Yamazaki Y, Teraki Y, Hayakawa J, Hayakawa K, Nuriya H, Kohara M, Shiohara T,. Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of im-munopathology in fixed drug eruption. Am J Pathol 2002; 161 (4): 1337-47.
8. Choi HJ, Ku JK, Kim MY, Kang H, Cho SH, Kim HO, Park YM,. Possible role of Fas/Fas ligand-mediated apopto-sis in the pathogenesis of fixed drug eruption. Br J Dermatol 2006; 154 (3): 419-25. (Pubitemid 43382646)
9. Teraki Y, Kokaji T, Shiohara T,. Expansion of IL-10-producing CD4+ and CD8+ T cells in fixed drug eruption. Dermatology 2006; 213 (2): 83-7. (Pubitemid 44215190)
10. Ozkaya E,. Fixed drug eruption: state of the art. J Dtsch Dermatol Ges 2008; 6 (3): 181-8. (Pubitemid 351361060)
11. Sehgal VN, Srivastava G,. Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int J Dermatol 2006; 45 (8): 897-908. (Pubitemid 44145022)
12. Shelley WB, Shelley ED,. Nonpigmen-ting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline. J Am Acad Dermatol 1987; 17 (3): 403-7. (Pubitemid 17126687)
13. Pellicano R, Ciavarella G, Lomuto M, Di Giorgio G,. Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22. J Am Acad Dermatol 1994; 30 (1): 52-4. (Pubitemid 24033819)
14. Gruber F, Stasić A, Lenković M, Brajac I,. Postcoital fixed drug eruption in a man sensitive to trimethoprim-sulpha-methoxazole. Clin Exp Dermatol 1997; 22 (3): 144-5. (Pubitemid 27448966)
15. Mahboob A, Haroon TS,. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998; 37 (11): 833-8. (Pubitemid 28545276)
16. Long CC, Finlay AY, Marks R,. Fixed drug eruption to mefenamic acid: a report of three cases. Br J Dermatol 1992; 126 (4): 409-11.
17. Rallis E, Rigopoulos D, Anyfantakis V, Kalogirou O, Christophidou E, Papadakis P, Katsambas A,. 'Dalmatian dog'-like skin eruption (two cases of multifocal fixed drug eruption induced by mefenamic acid). J Eur Acad Dermatol Venereol 2005; 19 (6): 753-5. (Pubitemid 41743335)
18. Dar NR, Masood S, Mustafvi SA,. Reticulated multifocal fixed drug eruption due to mefenamic acid-a new morphological pattern. J Coll Physicians Surg Pak 2005; 15 (9): 562-3. (Pubitemid 41535757)
19. Mizukawa Y, Shiohara T,. Nonpigmen-ting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses. Clin Exp Dermatol 2010; 35 (5): 493-7.
20. Mohamed KN,. Extensive fixed eruption to mefenamic acid. Aust N Z J Med 1991; 21 (2): 290-1.
21. Sowden JM, Smith AG,. Multifocal fixed drug eruption mimicking erythema multiforme. Clin Exp Dermatol 1990; 15 (5): 387-8. (Pubitemid 20277350)
22. Watson A, Watt G,. Fixed drug eruption to mefenamic acid. Australas J Dermatol 1986; 27 (1): 6-7. (Pubitemid 17172279)
23. Alanko K, Stubb S, Reitamo S,. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116 (4): 561-7. (Pubitemid 17036885)
24. Alanko K,. Topical provocation of fixed drug eruption. A study of 30 patients. Contact Dermatitis 1994; 31 (1): 25-7. (Pubitemid 24193850)
25. Lee AY,. Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Contact Dermatitis 1998; 38 (5): 258-60.
26. Ozkaya-Bayazit E, Bayazit H, Ozarma-gan G,. Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption. Contact Dermatitis 1999; 41 (4): 185-9. (Pubitemid 29427908)
27. Ozkaya-Bayazit E,. Topical provocation in fixed drug eruption due to metami-zol and naproxen. Clin Exp Dermatol 2004; 29 (4): 419-22. (Pubitemid 38980379)
28. Alanko K, Stubb S, Reitamo S,. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116 (4): 561-7. (Pubitemid 17036885)
29. Kauppinen K,. Cutaneous reactions to drugs with special reference to severe bullous mucocutaneous eruptions and sulphonamides. Acta Derm Venereol Suppl (Stockh). 1972; 68: 1-89.